Friday, 21 Feb 2020

Biologic/Novel Rx

Datesort descending Type Title Save
20 Nov 2015 News EU Endorses Biosimilar Etanercept (SB4) from Samsung/Biogen
22 Nov 2015 Social SB4 etanercept biosimilar (from Samsung/Biogen) approved by EMA for use in EU. https://t.co/xW1iXnAjRB
23 Nov 2015 News Power Doppler Ultrasound Detects Early Synovitis Change in APPRAISE Study
23 Nov 2015 News Interstitial Lung Disease Not Increased with Biologics
23 Nov 2015 Social The new Etanercept biosimilar (SB4) in the EU is named Benepali, EMA recommended for RA, PsA, SpA & plaque psoriasis https://t.co/6tbvbO7cHY
25 Nov 2015 News Eczema May Respond to Tofacitinib
27 Nov 2015 Social RCT shows Hidradenitis suppurativa pts respond well to anakinra (esp after wk 8) w/ less IFN and increased IL-22 https://t.co/OfndT569gt
02 Dec 2015 Social @RonanTKavanagh @psufka Impt issue, currently in large RCTs. Many reports in literature showing TCZ very effective in GCA, PMR & Takayasus
03 Dec 2015 News Rituximab's Efficacy May Be Correlated with CD4 T Cell Counts
17 Dec 2015 News Will the Balance of JAK inhibition Yield Better Outcomes? Results of New JAK inhibitor - Peficitinib
29 Dec 2015 News How I Choose Biologics (Best of 2015)
04 Jan 2016 News Tofacitinib Shows Promise in Alopecia, Eczema and Vitiligo
08 Jan 2016 News Combination or Monotherapy Tocilizumab in Rheumatoid Arthritis
22 Jan 2016 News TNF Inhibitors May Increase Cardiac Risks in Elderly
26 Jan 2016 News Biosimilar Reports - January 2016
29 Jan 2016 News Biosimilar of Remicade Works in Ankylosing Spondylitis
07 Feb 2016 Social Latex Allergies apply to some, biologics; but Cimzia, Actemra, Orencia, Kineret, Enbrel powder vials are safe https://t.co/DtqkwM9edD
09 Feb 2016 Social FDA arthritis advisory votes 21-3 in favor of approving the Celltrion CT-P13 (Inflectra) a biosimilar of infliximab https://t.co/YUXcj7K0Ow
13 Feb 2016 Social Biosimilars have changed FDA from the arbiter of drug safety/efficacy to a partner shepherding biosimilars to market https://t.co/G6NvuziaOk
16 Feb 2016 Social EMA & FDA rules: once biosimilar judged "highly similar" (via RCT,immunogenicity), Dz indication extrapolation is OK https://t.co/ZAKufTzgpE